Finance support for life sciences companies building in the U.S.
Research-driven companies need research-ready records
Payroll, contractors, lab costs, prototypes, software, materials, and research activities can affect tax, reporting, grants, investor review, and R&D credit analysis. We help organize the finance layer around that activity.
Pre-revenue does not mean finance can wait
MedTech and BioTech companies often raise capital before commercial revenue. We help build reporting around burn, runway, R&D spend, payroll, grants, milestones, and U.S. subsidiary activity.
Scientific teams create payroll complexity early
U.S. hires, consultants, advisors, executives, and research teams can trigger payroll, tax, benefits, state registrations, and equity reporting needs before the company has a mature finance function.
Global research teams need U.S. reporting that connects
We help align U.S. accounting, intercompany flows, grant or funding records, payroll, tax filings, and parent-company reporting for international life sciences companies.
The finance functions life sciences companies need before scale
Scientific progress needs financial structurebehind it.
MedTech and BioTech companies can spend years building value before revenue begins. Payroll, research costs, grants, prototypes, advisors, equity, and U.S. subsidiary activity all need to be tracked clearly for tax, investors, and leadership.
For international life sciences companies entering the U.S., the finance function has to support both scientific development and commercial readiness. Orbiss helps build the accounting, tax, payroll, and reporting infrastructure behind that path.
Frequently asked questions
MedTech and BioTech companies entering the U.S. need finance systems that support R&D, fundraising, payroll, reporting, and cross-border growth.
-
MedTech and BioTech companies should prioritize R&D cost tracking, payroll, contractor payments, grant or funding records, investor reporting, equity compensation, intercompany activity, and U.S. tax compliance.
Because many companies are pre-revenue or early revenue, finance reporting often focuses on burn, runway, milestones, and research spend.
-
Potentially. Companies with qualifying research activities may be eligible for the U.S. R&D tax credit, depending on the nature of the work, technical uncertainty, experimentation, documentation, and qualifying costs.
Qualified small businesses may be able to use a portion of the credit against payroll taxes, subject to IRS rules and limits.
-
R&D cost tracking supports tax positions, investor reporting, grant tracking, budget management, and future diligence. If expenses are not categorized correctly from the start, it can be difficult to reconstruct the data later.
Research-driven companies should build reporting around how scientific work actually happens.
-
A useful reporting pack may include burn rate, runway, R&D spend, payroll, contractor costs, milestone tracking, budget vs. actuals, cash position, grant-related activity, and entity-level reporting.
The goal is to connect financial activity to development progress.
-
U.S. payroll should be set up before hiring employees in the U.S. This may include federal withholding, state registrations, unemployment accounts, workers’ compensation, benefits decisions, and equity compensation coordination.
The requirements depend on where employees work and how the U.S. entity is structured.
-
A U.S. subsidiary should have bookkeeping, payroll entries, R&D cost tracking, expense workflows, intercompany documentation, tax-ready records, and reporting that supports both U.S. compliance and parent-company visibility.
GET IN TOUCH
Let's talk about your U.S. expansion
Tell us a bit about your business and the services you're exploring. A member of our team will review your message and get back to you shortly.
© 2026 Orbiss Inc. All rights reserved.